Xencor, Inc. (XNCR): Price and Financial Metrics
XNCR Price/Volume Stats
| Current price | $23.73 | 52-week high | $27.24 |
| Prev. close | $25.04 | 52-week low | $15.31 |
| Day low | $23.51 | Volume | 1,056,700 |
| Day high | $25.52 | Avg. volume | 610,824 |
| 50-day MA | $23.21 | Dividend yield | N/A |
| 200-day MA | $21.10 | Market Cap | 1.66B |
XNCR Stock Price Chart Interactive Chart >
Xencor, Inc. (XNCR) Company Bio
Xencor Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases and cancer. The company was founded in 1997 and is based in Monrovia, California.
XNCR Price Returns
| 1-mo | 0.42% |
| 3-mo | 12.62% |
| 6-mo | 19.85% |
| 1-year | 16.44% |
| 3-year | -39.17% |
| 5-year | -39.76% |
| YTD | 11.78% |
| 2023 | -18.47% |
| 2022 | -35.09% |
| 2021 | -8.04% |
| 2020 | 26.87% |
| 2019 | -4.89% |
Continue Researching XNCR
Want to see what other sources are saying about Xencor Inc's financials and stock price? Try the links below:Xencor Inc (XNCR) Stock Price | Nasdaq
Xencor Inc (XNCR) Stock Quote, History and News - Yahoo Finance
Xencor Inc (XNCR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...